medline.ch Onkologie Urologische Tumoren

	Identification of cancer-associated fibroblast characteristics for predicting outcome and response to immunotherapy in renal cell carcinoma. Comput Methods Biomech Biomed Engin Zhou JB, Li CX, Qian L, Chu JH. PMID: 40285654 [PubMed - as supplied by publisher]
	The Impact of Doxycycline as an Adjunctive Therapy on Prostate-Specific Antigen, Quality of Life, and Cognitive Function in Metastatic Prostate Cancer Patients: A Phase II Randomized Controlled Trial. Pharmaceutics Guzmán-Esquivel J, Garcia-Garcia HS, Hernández-Fuentes GA, Venegas-Ramírez J, Barajas-Mejía CD, Garza-Veloz I, Martinez-Fierro ML, Magaña-Vergara NE, Guzmán-Solórzano JA, Calvo-Soto P, Avila-Zamora ON, Fuentes-Murguia M, Ceja-Espíritu G, Delgado-Enciso I. PMID: 40284400 [PubMed]
	Paeonol Suppresses Bladder Cancer Progression via Apoptotic Pathways: Insights from In Vitro and In Vivo Studies. Pharmaceuticals (Basel) Ying L, Chen R, Guo R, Liang Y, Hao M, Chen X, Zhang W, Yu C, Yang Z. PMID: 40283909 [PubMed]
	Enhancing Prostate Cancer Diagnosis: A Comparative Analysis of Combined Fusion and Systematic Biopsy Methods-A Single-Center Study. J Clin Med Kania E, Janica M, Hrehoruk G, Kurowski P, Ostasiewicz A, Samocik P, Koz, Janica JR. PMID: 40283652 [PubMed]
	Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer? J Clin Med Tarantino G, Imbimbo C, Ferro M, Bianchi R, La Rocca R, Lucarelli G, Lasorsa F, Busetto GM, Finati M, Pastore AL, Al Salhi Y, Fuschi A, Terracciano D, Giampaglia G, Falabella R, Barone B, Fusco F, Del Giudice F, Crocetto F. PMID: 40283465 [PubMed]
	Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer. J Clin Med Smani S, DuBois J, Ajjawi I, Sohoni N, Choksi AU, Lokeshwar SD, Kim IY, Renzulli JF 2nd. PMID: 40283395 [PubMed]
	Radiobiological Meta-Analysis of the Response of Prostate Cancer to High-Dose-Rate Brachytherapy: Investigation of the Reduction in Control for Extreme Hypofractionation. Cancers (Basel) Kölmel EG, Pombar M, Pardo-Montero J. PMID: 40282514 [PubMed]
	Surveillance After Focal Therapy for Prostate Cancer: A Comprehensive Review. Cancers (Basel) Koehler J, Han S, Tremblay S, Hsu WW, Kalaycioglu B, Oto A, Sidana A. PMID: 40282513 [PubMed]
	Evaluation of Urinary miRNA in Renal Cell Carcinoma: A Systematic Review. Cancers (Basel) Cochetti G, Guadagni L, Paladini A, Russo M, La Mura R, Vitale A, Saqer E, Mangione P, Esposito R, Gioè M, Pastore F, De Angelis L, Ricci F, Mearini M, Vannuccini G, Mearini E. PMID: 40282512 [PubMed]
	Novel Urinary Biomarkers for the Detection of Bladder Cancer. Cancers (Basel) Oyaert M, Van Praet C, Delrue C, Speeckaert MM. PMID: 40282460 [PubMed]
	Diagnostic Capability and Improved Clinical Management of 18F-DCFPyL-PSMA PET/CT in Occult Biochemical Recurrence of Prostate Cancer After Prostatectomy. Cancers (Basel) Amorelli F, Foro P, Blanco JS, Ocanto A, Natali A, Fumado L, Plaza P. PMID: 40282448 [PubMed]
	Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data. Cancers (Basel) Fiorica F, Sava T, Giuliani J, Tebano U, Napoli G, Franceschetto A, Durante E, Campisi I, Palesandro E, Turco F, Buttigliero C, Munoz F, Tucci M. PMID: 40282432 [PubMed]
	Advancing Prostate Cancer Diagnostics: A ConvNeXt Approach to Multi-Class Classification in Underrepresented Populations. Bioengineering (Basel) Emegano DI, Mustapha MT, Ozsahin I, Ozsahin DU, Uzun B. PMID: 40281729 [PubMed]
	Sarcomatoid prostate carcinoma: a case report. BMC Urol Hafiani H, Hafiani I, Hafiani M. PMID: 40281516 [PubMed - indexed for MEDLINE]
	Preclinical and clinical evaluation of [(64)Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [(18)F]FDG imaging. Sci Rep Chen F, Zhang H, Zhan Y, Huang X, He Z, Ma D, Tang T, Li S. PMID: 40281230 [PubMed - indexed for MEDLINE]
	Mitigating the Risk of Skeletal Events in Metastatic Renal Cell Carcinoma. Eur Urol Focus Chen YW, McKay RR. PMID: 40280849 [PubMed - as supplied by publisher]
	Associations Between Prostate Cancer and Dementia: A Nationwide Study in Sweden. Eur Urol Oncol Crump C, Stattin P, Brooks JD, Sundquist J, Wei J, Sieh W, Sundquist K. PMID: 40280786 [PubMed - as supplied by publisher]
	Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol Dreyer T, Brandt S, Fabrin K, Azawi N, Vásquez JL, Ernst A, Dyrskjøt L, Jensen JB. PMID: 40280776 [PubMed - as supplied by publisher]
	Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study. JCO Clin Cancer Inform Shiota M, Nemoto S, Ikegami R, Tanegashima T, Blas L, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Kobayashi K, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Motoshima T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Eto M. PMID: 40279530 [PubMed - indexed for MEDLINE]
	Development and Evaluation of an Electronic Health Record-Derived Computable Phenotype to Identify Patients Undergoing Prostate Cancer Screening. JCO Clin Cancer Inform Lewicki P, Benhalim Y, Bradin J, Dryden K, Hakim H, Heasman B, Taylor A, Aqeel J, Vejalla A, Conte M, Richesson R, Stensland K. PMID: 40279529 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 166763

Seite 1 von 8339

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung